Story
Jiaxiang Interactive Repurchases 70,000 Shares for HK$93,800

Summary
Jiaxiang Interactive (HKG: 03798) announced it bought back 70,000 of its own shares on the open market for a total consideration of approximately HK$93,800 on September 21.
Jiaxiang Interactive (HKG: 03798) executed a share repurchase on September 21, acquiring 70,000 of its own shares for a total cost of approximately HK$93,800. The transaction was disclosed in a regulatory filing with the Hong Kong Stock Exchange.
Buyback Details
According to the announcement, the repurchase was conducted on the open market. The key figures from the transaction are as follows:
- Shares Repurchased: 70,000
- Total Consideration: HK$93,800
- Average Price Per Share: Approximately HK$1.34
This action is part of the company's ongoing capital management strategy and reduces the number of shares in public circulation.
AdMarket Implications
Share buyback programs are a common tool used by publicly traded companies to return capital to shareholders. Such moves can be interpreted by the market as a signal of management's confidence in the company's future prospects and a belief that the current stock price may be undervalued.
By reducing the number of outstanding shares, repurchases can also have an accretive effect on key financial metrics, such as earnings per share (EPS). Investors typically monitor buyback activity for insights into a company's financial health and its priorities for capital allocation.
Read next
More on Stocks
Lumentum Stock Jumps on AI Optical Interconnect Demo with Qualcomm, Corning
Lumentum shares rose after the company, alongside partners Qualcomm and Corning, demonstrated a new high-density optical interconnect system designed for next-generation AI data centers.

Geek+ Repurchases 884,000 Shares for HK$7.23 Million
Logistics robotics firm Geek+ (2590.HK) announced it conducted a share buyback on September 21, 2026, purchasing 884,000 shares for a total consideration of HK$7.2314 million.

Xinhua United Investment Proposes 20-for-1 Share Consolidation
Xinhua United Investment's board has proposed a reverse stock split to consolidate every 20 existing shares into one new share, aiming to adjust its capital structure.

Laekna's Cancer Drug Opatisumimab Earns Late-Breaking Abstract Status at ESMO Congress
Laekna announced its pivotal Phase IIb study for the bispecific antibody opatisumimab in late-stage neuroendocrine carcinoma has been selected for a Late-Breaking Abstract oral presentation at the European Society for Medical Oncology Congress. The company will also present findings from two other studies in proffered oral sessions.